Advertisement
Screener

Flexion Therapeutics, Inc. Research and Development Expense

Flexion Therapeutics, Inc. Research and Development Expense

Flexion Therapeutics, Inc. reported Research and Development Expense of $14.77 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2021-11-12

  • Flexion Therapeutics, Inc. research and development expense for the quarter ending 2021-09-30 was $14.77M, a 46.36% increase year-over-year.
  • Flexion Therapeutics, Inc. research and development expense for the quarter ending 2021-06-30 was $12.67M, a 1.30% increase year-over-year.
  • Flexion Therapeutics, Inc. research and development expense for the quarter ending 2021-03-31 was $14.05M, a 33.53% decline year-over-year.
  • Flexion Therapeutics, Inc. research and development expense for the quarter ending 2020-12-31 was $10.59M, a 37.95% decline year-over-year.
  • Flexion Therapeutics, Inc. research and development expense for fiscal 2020 was $54.33M, a 21.90% decline from fiscal 2019.
  • Flexion Therapeutics, Inc. research and development expense for fiscal 2019 was $69.56M, a 31.05% increase from fiscal 2018.
  • Flexion Therapeutics, Inc. research and development expense for fiscal 2018 was $53.08M.
  • Flexion Therapeutics, Inc. research and development expense for fiscal 2016 was $41.31M, a 26.38% increase from fiscal 2015.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filedResearch and Development Expense 77 month
2021-09-30$14.77M
10-Q · filed 2021-11-12
$27.44M
derived: sum of 2 quarters · filed 2021-11-12
$41.49M
10-Q · filed 2021-11-12
$52.08M
derived: sum of 4 quarters · filed 2021-11-12
2021-06-30$12.67M
10-Q · filed 2021-08-04
$26.72M
10-Q · filed 2021-08-04
$37.31M
derived: sum of 3 quarters · filed 2021-08-04
$47.40M
derived: sum of 4 quarters · filed 2021-11-12
2021-03-31$14.05M
10-Q · filed 2021-05-12
$24.64M
derived: sum of 2 quarters · filed 2021-05-12
$34.73M
derived: sum of 3 quarters · filed 2021-11-12
$47.24M
derived: sum of 4 quarters · filed 2021-11-12
2020-12-31$10.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$20.68M
derived: sum of 2 quarters · filed 2021-11-12
$33.19M
derived: sum of 3 quarters · filed 2021-11-12
$54.33M
10-K · filed 2021-03-10
2020-09-30$10.09M
10-Q · filed 2021-11-12
$22.60M
derived: sum of 2 quarters · filed 2021-11-12
$43.73M
10-Q · filed 2021-11-12
$60.80M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$12.51M
10-Q · filed 2021-08-04
$33.64M
10-Q · filed 2021-08-04
$50.71M
derived: sum of 3 quarters · filed 2021-08-04
$71.65M
derived: sum of 4 quarters · filed 2021-08-04
2020-03-31$21.13M
10-Q · filed 2021-05-12
$38.20M
derived: sum of 2 quarters · filed 2021-05-12
$59.14M
derived: sum of 3 quarters · filed 2021-05-12
$75.27M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$17.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$38.01M
derived: sum of 2 quarters · filed 2021-03-10
$54.13M
derived: sum of 3 quarters · filed 2021-03-10
$69.56M
10-K · filed 2021-03-10
2019-09-30$20.94M
10-Q · filed 2020-11-04
$37.06M
derived: sum of 2 quarters · filed 2020-11-04
$52.49M
10-Q · filed 2020-11-04
$67.34M
derived: sum of 4 quarters · filed 2021-03-10
2019-06-30$16.13M
10-Q · filed 2020-08-05
$31.55M
10-Q · filed 2020-08-05
$46.41M
derived: sum of 3 quarters · filed 2021-03-10
$59.98M
derived: sum of 4 quarters · filed 2021-03-10
2019-03-31$15.42M
10-Q · filed 2020-05-07
$30.28M
derived: sum of 2 quarters · filed 2021-03-10
$43.86M
derived: sum of 3 quarters · filed 2021-03-10
$56.95M
derived: sum of 4 quarters · filed 2021-03-10
2018-12-31$14.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$28.43M
derived: sum of 2 quarters · filed 2021-03-10
$41.53M
derived: sum of 3 quarters · filed 2021-03-10
$53.08M
10-K · filed 2021-03-10
2018-09-30$13.58M
10-Q · filed 2019-11-07
$26.67M
derived: sum of 2 quarters · filed 2019-11-07
$38.22M
10-Q · filed 2019-11-07
$54.08M
derived: sum of 4 quarters · filed 2020-05-20
2018-06-30$13.09M
10-Q · filed 2019-08-06
$24.64M
10-Q · filed 2019-08-06
$40.51M
derived: sum of 3 quarters · filed 2020-05-20
$53.35M
derived: sum of 4 quarters · filed 2020-05-20
2018-03-31$11.55M
10-Q · filed 2019-05-08
$27.41M
derived: sum of 2 quarters · filed 2020-05-20
$40.26M
derived: sum of 3 quarters · filed 2020-05-20
$52.03M
derived: sum of 4 quarters · filed 2020-05-20
2017-12-31$15.86M
derived: 8-K 12 month − 10-Q 9 month · filed 2020-05-20
$28.71M
derived: sum of 2 quarters · filed 2020-05-20
$40.48M
derived: sum of 3 quarters · filed 2020-05-20
$51.23M
8-K · filed 2020-05-20
2017-09-30$12.85M
10-Q · filed 2018-11-07
$24.61M
derived: sum of 2 quarters · filed 2018-11-07
$35.37M
10-Q · filed 2018-11-07
$46.75M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$11.77M
10-Q · filed 2018-08-07
$22.52M
10-Q · filed 2018-08-07
$33.91M
derived: sum of 3 quarters · filed 2019-02-28
$42.95M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$10.76M
10-Q · filed 2018-05-08
$22.14M
derived: sum of 2 quarters · filed 2019-02-28
$31.18M
derived: sum of 3 quarters · filed 2019-02-28
$40.09M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$11.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$20.43M
derived: sum of 2 quarters · filed 2019-02-28
$29.33M
derived: sum of 3 quarters · filed 2019-02-28
$41.31M
10-K · filed 2019-02-28
$41.31M
10-K · filed 2017-03-10
2016-09-30$9.05M
10-Q · filed 2017-11-06
$17.95M
derived: sum of 2 quarters · filed 2017-11-06
$29.93M
10-Q · filed 2017-11-06
$38.90M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$8.90M
10-Q · filed 2017-08-08
$20.89M
10-Q · filed 2017-08-08
$29.85M
derived: sum of 3 quarters · filed 2018-03-08
$37.68M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$11.98M
10-Q · filed 2017-05-05
$20.95M
derived: sum of 2 quarters · filed 2018-03-08
$28.78M
derived: sum of 3 quarters · filed 2018-03-08
$38.42M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$8.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$16.80M
derived: sum of 2 quarters · filed 2018-03-08
$26.44M
derived: sum of 3 quarters · filed 2018-03-08
$32.69M
10-K · filed 2018-03-08
$32.69M
10-K · filed 2016-03-11
2015-09-30$7.83M
10-Q · filed 2016-11-07
$7.83M
10-Q · filed 2015-11-09
$17.47M
derived: sum of 2 quarters · filed 2016-11-07
$23.72M
10-Q · filed 2016-11-07
$23.72M
10-Q · filed 2015-11-09
$29.22M
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$9.64M
10-Q · filed 2016-08-03
$9.64M
10-Q · filed 2015-08-06
$15.89M
10-Q · filed 2016-08-03
$15.90M
10-Q · filed 2015-08-06
$21.39M
derived: sum of 3 quarters · filed 2017-03-10
$26.05M
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$6.25M
10-Q · filed 2016-05-12
$6.26M
10-Q · filed 2015-05-08
$11.75M
derived: sum of 2 quarters · filed 2017-03-10
$16.41M
derived: sum of 3 quarters · filed 2017-03-10
$20.03M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$5.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$10.16M
derived: sum of 2 quarters · filed 2017-03-10
$13.77M
derived: sum of 3 quarters · filed 2017-03-10
$17.92M
10-K · filed 2017-03-10
2014-09-30$4.66M
10-Q · filed 2015-11-09
$8.27M
derived: sum of 2 quarters · filed 2015-11-09
$12.42M
10-Q · filed 2015-11-09
2014-06-30$3.61M
10-Q · filed 2015-08-06
$7.77M
10-Q · filed 2015-08-06
2014-03-31$4.15M
10-Q · filed 2015-05-08
$46.45M
10-Q · filed 2014-05-12
2013-12-31$11.06M
10-K · filed 2016-03-11
2013-09-30$2.57M
10-Q · filed 2014-11-14
$5.64M
derived: sum of 2 quarters · filed 2014-11-14
$8.82M
10-Q · filed 2014-11-14
2013-06-30$3.07M
10-Q · filed 2014-08-08
$6.25M
10-Q · filed 2014-08-08
2013-03-31$3.19M
10-Q · filed 2014-05-12
2012-12-31$11.07M
10-K · filed 2015-03-24